RU2014138694A - Composition for stimulating metabolic processes, the immune system, preventing diarrhea diseases - Google Patents
Composition for stimulating metabolic processes, the immune system, preventing diarrhea diseases Download PDFInfo
- Publication number
- RU2014138694A RU2014138694A RU2014138694A RU2014138694A RU2014138694A RU 2014138694 A RU2014138694 A RU 2014138694A RU 2014138694 A RU2014138694 A RU 2014138694A RU 2014138694 A RU2014138694 A RU 2014138694A RU 2014138694 A RU2014138694 A RU 2014138694A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- immune system
- metabolic processes
- succinic acid
- iodinol
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract 5
- 210000000987 immune system Anatomy 0.000 title claims abstract 5
- 230000004060 metabolic process Effects 0.000 title claims abstract 5
- 239000000203 mixture Substances 0.000 title claims abstract 5
- 230000004936 stimulating effect Effects 0.000 title claims abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract 12
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 claims abstract 4
- 239000007864 aqueous solution Substances 0.000 claims abstract 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims abstract 4
- 229960001614 levamisole Drugs 0.000 claims abstract 4
- 239000001384 succinic acid Substances 0.000 claims abstract 4
- 230000002265 prevention Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Состав для стимуляции метаболических процессов, системы иммунитета, профилактики заболеваний диареей, включающий янтарную кислоту, йодинол, отличающийся тем, что дополнительно содержит АСД второй фракции при следующем соотношении компонентов на 1000 мл водного раствора:Янтарная кислота - 10,0 гЙодинол - 250 млАСД второй фракции - 40 мл.2. Состав для стимуляции метаболических процессов, системы иммунитета, профилактики заболеваний диареей, включающий янтарную кислоту, йодинол, отличающийся тем, что дополнительно содержит левамизол при следующем соотношении компонентов на 1000 мл водного раствора:Янтарная кислота - 10,0 гЙодинол - 250 млЛевамизол - 10,0 г.1. Composition for stimulating metabolic processes, the immune system, preventing diarrhea, including succinic acid, iodinol, characterized in that it additionally contains an ASD of the second fraction in the following ratio of components per 1000 ml of an aqueous solution: Succinic acid - 10.0 gIodinol - 250 ml of ASD the second fraction - 40 ml. 2. Composition for stimulating metabolic processes, the immune system, preventing diarrhea diseases, including succinic acid, iodinol, characterized in that it additionally contains levamisole in the following ratio of components per 1000 ml of an aqueous solution: succinic acid - 10.0 g Iodinol - 250 ml Levamisole - 10.0 g.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014138694A RU2620554C2 (en) | 2014-09-24 | 2014-09-24 | Content for stimulating metabolic processes, immune system, prevention the diseases and diarrhea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014138694A RU2620554C2 (en) | 2014-09-24 | 2014-09-24 | Content for stimulating metabolic processes, immune system, prevention the diseases and diarrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014138694A true RU2014138694A (en) | 2016-04-10 |
| RU2620554C2 RU2620554C2 (en) | 2017-05-26 |
Family
ID=55647631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014138694A RU2620554C2 (en) | 2014-09-24 | 2014-09-24 | Content for stimulating metabolic processes, immune system, prevention the diseases and diarrhea |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2620554C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2671635C1 (en) * | 2017-07-10 | 2018-11-06 | Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" | Composition for stimulating immune-metabolic processes and prevention of diarrhea syndrome of newborn calves |
| RU2681523C2 (en) * | 2017-07-17 | 2019-03-07 | Федеральное государственное бюджетное научное учреждение "Курский федеральный аграрный научный центр" | Composition for the treatment of diarrheal syndrome in intestinal diseases of calves in preweaning period |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2303979C2 (en) * | 2005-05-23 | 2007-08-10 | Управление ветеринарии Курской области | Method for producing succinic biostimulator for increasing organism resistance |
| RU2521369C1 (en) * | 2013-02-07 | 2014-06-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации | Agent or stimulation of metabolic processes, prevention and treatment of gastrointestinal diseases in calves in early postnatal period |
| CN103550628A (en) * | 2013-11-04 | 2014-02-05 | 天农大（天津）生物科技有限公司 | Traditional Chinese medicinal composition for treating livestock and poultry diarrhea and preparation method thereof |
-
2014
- 2014-09-24 RU RU2014138694A patent/RU2620554C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2620554C2 (en) | 2017-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500894A1 (en) | Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab | |
| EA201692177A1 (en) | CONNECTIONS AND COMPOSITIONS AS AN AGONISTS OF TOLL-LIKE RECEPTOR 7 | |
| EA201692201A1 (en) | CONNECTIONS AND COMPOSITIONS AS AN AGONISTS OF TOLL-LIKE RECEPTOR 7 | |
| WO2015168379A3 (en) | Combination vaccine devices and methods of killing cancer cells | |
| GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| PH12017502255B1 (en) | Nrf2 regulators | |
| MX2016016666A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| MX2016015093A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| SG10201903823QA (en) | Methods and compositions relating to microbial treatment and diagnosis of disorders | |
| MY191581A (en) | Anti-pd-1 antibodies | |
| MX2018001006A (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ADENOVIRAL VECTOR. | |
| PH12018500578A1 (en) | Methods of treating inflammatory diseases | |
| EA201890815A1 (en) | AMINO ACID COMPOSITIONS WITH MODIFIED DELIVERY FOR ORAL ADMINISTRATION | |
| EA201791467A1 (en) | AQUEOUS OPHTHALMIC SOLUTION | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| MX2019010367A (en) | Aqueous anti-pd-l1 antibody formulation. | |
| PH12017500348A1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
| WO2016138538A3 (en) | Therapeutic use of integrin-binding antibodies | |
| IN2014CH00840A (en) | ||
| PH12018550097A1 (en) | Infant formula comprising human milk peptides | |
| MX2019003755A (en) | Dosing regimen of avelumab for the treatment of cancer. | |
| PH12017501735B1 (en) | Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same | |
| CL2016002321A1 (en) | Compounds derived from 2-8-5-chloropyrimidin-2-ylamino-6,7,8,9-tetrahydro-5h-pyrido3,2-bindol-5-ylacetic acid, modulators of the prostaglandin d2 receptor pharmaceutical composition and its use for the treatment of diseases allergic immune disorders. | |
| MA42611A (en) | COMBINED TREATMENT INCLUDING THE ADMINISTRATION OF 2-AMINO-3,5,5-TRIFLUORO-3,4,5,6-TETRAHYDROPYRIDINES | |
| RU2014138694A (en) | Composition for stimulating metabolic processes, the immune system, preventing diarrhea diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20190925 |